Modern therapies such as stem cell transplant and immune therapy have made high-risk neuroblastoma a survivable disease for some children, but little is known about the chronic health issues experienced by survivors. In order to ensure that future treatments address both the chance and the quality of cure, this consortium aims to examine the impact of neuroblastoma therapy on survivors' growth, pubertal development and long-term health. This grant is named for and funded by the "Just Do It...…and be done with it" Hero Fund created in honor of Sara Martorano who doesn't let anything dim her sparkle and has a compassionate heart and smile. It also celebrates the courage of all cancer kids through treatment and the support of their family and friends.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

Modern therapies such as stem cell transplant and immune therapy have made high-risk neuroblastoma a survivable disease for some children, but little is known about the chronic health issues experienced by survivors. In order to ensure that future treatments address both the chance and the quality of cure, this consortium aims to examine the impact of neuroblastoma therapy on survivors' growth, pubertal development and long-term health. This grant is generously supported by the "Just Do It...…and be done with it" Hero Fund created in honor of Sara Martorano who doesn't let anything dim her sparkle and has a compassionate heart and smile. It also celebrates the courage of all cancer kids through treatment and the support of their family and friends.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

The International Neuroblastoma Risk Group (INRG) Task Force has collected data on over 11,500 children with neuroblastoma. These data are available to researchers from around the world, and seminal discoveries have already been made using this unique collection of patient data. However, the current application housing the INRG data has significant limitations, and this project develops tools to overcome those. The INRG has recently reported racial disparities in outcome in neuroblastoma, and studies indicate genetic factors contribute to the poor outcome seen in the black cohort. Banked DNA samples will be identified and used to learn the variables contributing to these disparities. The goal of the Interactive INRG database is to transform neuroblastoma research by enabling studies on large international cohorts of patients never before possible. Funds administered by the University of Chicago.  This grant is generously supported by the “Just Do It…and be done with it” Hero Fund created in honor of Sara Martorano and celebrates the courage of all kids with cancer through treatment and the support of their family and friends.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: the Children's Hospital Los Angeles, Los Angeles, CA.